home / stock / nspr / nspr news


NSPR News and Press, InspireMD Inc. From 08/10/20

Stock Information

Company Name: InspireMD Inc.
Stock Symbol: NSPR
Market: NASDAQ
Website: inspiremd.com

Menu

NSPR NSPR Quote NSPR Short NSPR News NSPR Articles NSPR Message Board
Get NSPR Alerts

News, Short Squeeze, Breakout and More Instantly...

NSPR - InspireMD Regains Compliance with NYSE AMERICAN Listing Standards

TEL AVIV, Israel, Aug. 10, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that as of August 7, 2020, the Company h...

NSPR - InspireMD's (NSPR) CEO Marvin Slosman on Q2 2020 Results - Earnings Call Transcript

InspireMD, Inc. (NSPR) Q2 2020 Earnings Conference Call August 5, 2020 8:30 AM ET Company Participants Scott Gordon – President of CORE IR, Investor Relations Marvin Slosman – Chief Executive Officer Craig Shore – Chief Financial Officer Conference Call Pa...

NSPR - InspireMD Announces Second Quarter 2020 Financial Results

 In the second quarter the Company was granted approval to market its CGuard™ MicroNet stent in Brazil and completed an $11.5 million capital raise; reported outstanding results in studies treating patients with the CGuard™ MicroNET stent Management to host in...

NSPR - UPDATE: InspireMD to Report Second Quarter 2020 Financial Results on Wednesday, August 5, 2020 and Provide Corporate Update

TEL AVIV, Israel, July 29, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announces it will report fiscal second quarter 2020 finan...

NSPR - InspireMD to Report Second Quarter 2020 Financial Results on Wednesday, August 5, 2020 and Provide Corporate Update

TEL AVIV, Israel, July 28, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announces it will report fiscal second quarter 2020 finan...

NSPR - Are Penny Stocks Part Of Your Investing Strategy? 4 To Watch

Looking For penny Stocks To Buy? Penny stocks aren’t for everyone. But that’s not because they aren’t worth it. What it does mean, however, is that new traders tend to treat these cheap stocks like lottery tickets. The fact of the matter is that it doesn’t need to...

NSPR - InspireMD Gains Registration Clearance of its CGuard(TM) Embolic Prevention System (EPS) in Brazil

TEL AVIV, Israel, July 23, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease (CAD), today announced it has obtained registration from the Brazilian...

NSPR - Penny Stocks To Watch Before July 2020

Will July Bring New Highs For These Penny Stocks? The countdown has begun for a few penny stocks . In just 3 more sessions, we will be on the eve of a new month and quarter. While summer months are typically quiet for the stock market, this year’s a bit different. We really didn’...

NSPR - InspireMD Announces Late-Breaking Presentation of Early SIBERIA Clinical Trial Results to be Featured in an e-Course at EuroPCR

TEL AVIV, Israel, June 25, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease treatment, announced today that early results from the investigator-initia...

NSPR - InspireMD Announces Publication of 12-Month Results of CGuard(TM) EPS PARADIGM Trial in EuroIntervention

Results indicate that 12 months after carotid intervention the CGuard EPS MicroNET-covered stent delivers sustained protection against postprocedural neurologic events TEL AVIV, Israel, June 10, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard...

Previous 10 Next 10